1. Characterizing proton-activated materials to develop PET-mediated proton range verification markers. (20th May 2016) Authors: Cho, Jongmin; Ibbott, Geoffrey S; Kerr, Matthew D; Amos, Richard A; Stingo, Francesco C; Marom, Edith M; Truong, Mylene T; Palacio, Diana M; Betancourt, Sonia L; Erasmus, Jeremy J; DeGroot, Patricia M; Carter, Brett W; Gladish, Gregory W; Sabloff, Bradley S; Benveniste, Marcelo F; Godoy, Myrna C;... Journal: Physics in medicine & biology Issue: Volume 61:Number 11(2016:Jun.) Page Start: N291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chest. (2020) Authors: Carter, Brett W; Rosado de Christenson, Melissa L; Lichtenberger, John P; Martínez-Jiménez, Santiago Record Type: Book Extent: 1 online resource, illustrations (colour) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Imaging of Combat-Related Thoracic Trauma – Blunt Trauma and Blast Lung Injury. Issue 3 (28th December 2017) Authors: Lichtenberger, John P; Kim, Andrew M; Fisher, Dane; Tatum, Peter S; Neubauer, Brian; Peterson, P Gabriel; Carter, Brett W Journal: Military medicine Issue: Volume 183:Issue 3/4(2018) Page Start: e89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Imaging of Combat-Related Thoracic Trauma – Review of Penetrating Trauma. Issue 3 (27th December 2017) Authors: Lichtenberger, John P; Kim, Andrew M; Fisher, Dane; Tatum, Peter S; Neubauer, Brian; Peterson, P Gabriel; Carter, Brett W Journal: Military medicine Issue: Volume 183:Issue 3/4(2018) Page Start: e81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Imaging of the mediastinum. (2021) Editors: Carter, Brett W Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Oncology. (2019) Authors: Shaaban, Akram M; Glastonbury, Christine M; Rosado de Christenson, Melissa L; Carter, Brett W Record Type: Book Extent: 1 online resource, illustrations (colour) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non–small cell lung cancer and a poor performance status. Issue 2 (4th August 2020) Authors: Alessi, Joao V; Ricciuti, Biagio; Jiménez-Aguilar, Elizabeth; Hong, Fangxin; Wei, Zihan; Nishino, Mizuki; Plodkowski, Andrew J; Sawan, Peter; Luo, Jia; Rizvi, Hira; Carter, Brett W; Heymach, John V; Altan, Mehmet; Hellmann, Matthew; Awad, Mark Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non–small cell lung cancer and a poor performance status. Issue 2 (4th August 2020) Authors: Alessi, Joao V; Ricciuti, Biagio; Jiménez-Aguilar, Elizabeth; Hong, Fangxin; Wei, Zihan; Nishino, Mizuki; Plodkowski, Andrew J; Sawan, Peter; Luo, Jia; Rizvi, Hira; Carter, Brett W; Heymach, John V; Altan, Mehmet; Hellmann, Matthew; Awad, Mark Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non–small cell lung cancer and a poor performance status. Issue 2 (4th August 2020) Authors: Alessi, Joao V; Ricciuti, Biagio; Jiménez-Aguilar, Elizabeth; Hong, Fangxin; Wei, Zihan; Nishino, Mizuki; Plodkowski, Andrew J; Sawan, Peter; Luo, Jia; Rizvi, Hira; Carter, Brett W; Heymach, John V; Altan, Mehmet; Hellmann, Matthew; Awad, Mark Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non–small cell lung cancer and a poor performance status. Issue 2 (4th August 2020) Authors: Alessi, Joao V; Ricciuti, Biagio; Jiménez-Aguilar, Elizabeth; Hong, Fangxin; Wei, Zihan; Nishino, Mizuki; Plodkowski, Andrew J; Sawan, Peter; Luo, Jia; Rizvi, Hira; Carter, Brett W; Heymach, John V; Altan, Mehmet; Hellmann, Matthew; Awad, Mark Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗